Recurrence of anti-GBM disease 8 years after renal transplantation.
Khandelwal
Mukesh
M
Division of Nephrology, University Health Network, Toronto, Ontario, Canada.
McCormick
Brendan B
BB
Lajoie
Ginette
G
Sweet
Joan
J
Cole
Edward
E
Cattran
Daniel C
DC
D019867:Anti-Glomerular Basement Membrane Disease / Q000150:complications* / Q000175:diagnosis; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000188:drug therapy* / Q000517:prevention & control; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007676:Kidney Failure, Chronic / Q000209:etiology / Q000601:surgery*; D016030:Kidney Transplantation / Q000009:adverse effects* / Q000379:methods; D008775:Methylprednisolone / Q000008:administration & dosage*; D008875:Middle Aged; D011241:Prednisone / Q000008:administration & dosage*; D012008:Recurrence; D018570:Risk Assessment; D013997:Time Factors; D014184:Transplantation, Homologous; D016896:Treatment Outcome
D007166:Immunosuppressive Agents; D011241:Prednisone; D008775:Methylprednisolone